Total Payments
$806,616
2024 Payments
$165,849
Companies
13
Transactions
390
Medicare Patients
7,681
Medicare Billing
$208,900
Payment Breakdown by Category
Consulting$474,730 (58.9%)
Other$281,131 (34.9%)
Travel$42,321 (5.2%)
Food & Beverage$8,433 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $474,730 | 134 | 58.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $281,131 | 71 | 34.9% |
| Travel and Lodging | $42,321 | 83 | 5.2% |
| Food and Beverage | $8,433 | 102 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Daiichi Sankyo Inc. | $337,098 | 91 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $334,202 | 195 | $0 (2024) |
| Genentech USA, Inc. | $97,434 | 74 | $0 (2020) |
| AstraZeneca UK Limited | $22,151 | 13 | $0 (2024) |
| Roche Products Limited | $6,474 | 3 | $0 (2022) |
| ABBVIE INC. | $3,850 | 4 | $0 (2024) |
| Boehringer Ingelheim International GmbH | $2,700 | 2 | $0 (2021) |
| BeiGene USA, Inc. | $2,250 | 1 | $0 (2024) |
| Genentech, Inc. | $129.70 | 2 | $0 (2019) |
| Olympus America Inc. | $126.66 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $165,849 | 50 | Daiichi Sankyo Inc. ($123,165) |
| 2023 | $167,587 | 63 | Daiichi Sankyo Inc. ($131,346) |
| 2022 | $94,470 | 38 | Daiichi Sankyo Inc. ($67,416) |
| 2021 | $26,626 | 16 | Daiichi Sankyo Inc. ($15,170) |
| 2020 | $32,849 | 10 | Boehringer Ingelheim Pharmaceuticals, Inc. ($32,706) |
| 2019 | $72,282 | 50 | Boehringer Ingelheim Pharmaceuticals, Inc. ($44,464) |
| 2018 | $119,253 | 69 | Boehringer Ingelheim Pharmaceuticals, Inc. ($89,785) |
| 2017 | $127,699 | 94 | Boehringer Ingelheim Pharmaceuticals, Inc. ($86,364) |
All Payment Transactions
390 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $550.00 | General |
| 11/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,875.00 | General |
| 10/30/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Consulting Fee | Cash or cash equivalent | $18,296.25 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Consulting Fee | Cash or cash equivalent | $12,000.00 | General |
| Category: RESPIRATORY | ||||||
| 10/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Travel and Lodging | In-kind items and services | $140.00 | General |
| Category: RESPIRATORY | ||||||
| 10/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: RESPIRATORY | ||||||
| 09/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $767.10 | General |
| 09/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $123.86 | General |
| 09/18/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Consulting Fee | Cash or cash equivalent | $2,975.00 | General |
| Category: ONCOLOGY | ||||||
| 09/11/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Consulting Fee | Cash or cash equivalent | $3,570.00 | General |
| Category: ONCOLOGY | ||||||
| 09/11/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Consulting Fee | Cash or cash equivalent | $3,421.25 | General |
| Category: ONCOLOGY | ||||||
| 09/11/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Consulting Fee | Cash or cash equivalent | $2,677.50 | General |
| Category: ONCOLOGY | ||||||
| 09/03/2024 | BeiGene USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,250.00 | General |
| 08/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,375.00 | General |
| 08/20/2024 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $3,490.50 | General |
| 08/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $48.98 | General |
| 08/07/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Consulting Fee | Cash or cash equivalent | $2,975.00 | General |
| Category: ONCOLOGY | ||||||
| 07/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $116.42 | General |
| 07/24/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Consulting Fee | Cash or cash equivalent | $7,288.75 | General |
| Category: ONCOLOGY | ||||||
| 07/24/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Consulting Fee | Cash or cash equivalent | $6,693.75 | General |
| Category: ONCOLOGY | ||||||
| 07/24/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Consulting Fee | Cash or cash equivalent | $1,041.25 | General |
| Category: ONCOLOGY | ||||||
| 07/10/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Consulting Fee | Cash or cash equivalent | $2,826.25 | General |
| Category: ONCOLOGY | ||||||
| 06/26/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Consulting Fee | Cash or cash equivalent | $4,611.25 | General |
| Category: ONCOLOGY | ||||||
| 06/26/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Consulting Fee | Cash or cash equivalent | $3,570.00 | General |
| Category: ONCOLOGY | ||||||
| 06/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Consulting Fee | Cash or cash equivalent | $3,750.00 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 1,037 | 1,316 | $269,465 | $29,320 |
| 2022 | 9 | 1,779 | 2,279 | $406,522 | $46,307 |
| 2021 | 9 | 2,572 | 3,550 | $579,868 | $71,354 |
| 2020 | 8 | 2,293 | 3,105 | $485,826 | $61,920 |
Total Patients
7,681
Total Services
10,250
Medicare Billing
$208,900
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 71250 | Ct scan of chest without contrast | Facility | 2023 | 164 | 169 | $63,121 | $6,850 | 10.9% |
| 71275 | Ct scan of blood vessels of chest with contrast | Facility | 2023 | 82 | 84 | $55,532 | $6,095 | 11.0% |
| 71045 | X-ray of chest, 1 view | Facility | 2023 | 443 | 705 | $43,191 | $5,046 | 11.7% |
| 71260 | Ct scan of chest with contrast | Facility | 2023 | 85 | 88 | $39,972 | $3,778 | 9.5% |
| 75574 | Ct scan of blood vessels and grafts of heart with contrast | Facility | 2023 | 16 | 16 | $13,700 | $1,529 | 11.2% |
| 71260 | Ct scan of chest with contrast | Office | 2023 | 27 | 28 | $12,754 | $1,186 | 9.3% |
| 71271 | Low dose ct scan of chest for lung cancer screening | Facility | 2023 | 22 | 22 | $6,773 | $1,166 | 17.2% |
| 71250 | Ct scan of chest without contrast | Office | 2023 | 29 | 29 | $10,810 | $1,127 | 10.4% |
| 71046 | X-ray of chest, 2 views | Facility | 2023 | 132 | 137 | $10,315 | $1,119 | 10.8% |
| 74160 | Ct scan of abdomen with contrast | Facility | 2023 | 20 | 21 | $9,772 | $1,021 | 10.5% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 17 | 17 | $3,525 | $401.94 | 11.4% |
| 71250 | Ct scan of chest without contrast | Facility | 2022 | 217 | 225 | $82,300 | $9,427 | 11.5% |
| 71045 | X-ray of chest, 1 view | Facility | 2022 | 782 | 1,243 | $74,599 | $9,214 | 12.4% |
| 71275 | Ct scan of blood vessels of chest with contrast | Facility | 2022 | 92 | 93 | $59,994 | $6,529 | 10.9% |
| 71260 | Ct scan of chest with contrast | Facility | 2022 | 124 | 128 | $56,785 | $5,636 | 9.9% |
| 71046 | X-ray of chest, 2 views | Facility | 2022 | 321 | 339 | $24,921 | $2,775 | 11.1% |
| 75574 | Ct scan of blood vessels and grafts of heart with contrast | Facility | 2022 | 27 | 27 | $22,470 | $2,595 | 11.5% |
| 71250 | Ct scan of chest without contrast | Office | 2022 | 60 | 62 | $22,574 | $2,497 | 11.1% |
| 71271 | Low dose ct scan of chest for lung cancer screening | Facility | 2022 | 38 | 38 | $11,374 | $2,093 | 18.4% |
| 74160 | Ct scan of abdomen with contrast | Facility | 2022 | 31 | 33 | $14,976 | $1,654 | 11.0% |
| 71260 | Ct scan of chest with contrast | Office | 2022 | 29 | 32 | $14,073 | $1,369 | 9.7% |
| 75561 | Mri scan of heart before and after contrast | Facility | 2022 | 15 | 15 | $13,540 | $1,362 | 10.1% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 43 | 44 | $8,916 | $1,155 | 13.0% |
| 71045 | X-ray of chest, 1 view | Facility | 2021 | 1,167 | 2,054 | $118,798 | $15,543 | 13.1% |
| 71250 | Diagnostic ct scan of chest | Facility | 2021 | 307 | 328 | $115,072 | $14,006 | 12.2% |
About Jonathan Chung
Jonathan Chung is a Diagnostic Radiology healthcare provider based in San Diego, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508878752.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jonathan Chung has received a total of $806,616 in payments from pharmaceutical and medical device companies, with $165,849 received in 2024. These payments were reported across 390 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($474,730).
As a Medicare-enrolled provider, Chung has provided services to 7,681 Medicare beneficiaries, totaling 10,250 services with total Medicare billing of $208,900. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Diagnostic Radiology
- Other Specialties Diagnostic Radiology
- Location San Diego, CA
- Active Since 08/13/2006
- Last Updated 01/09/2024
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1508878752
Products in Payments
- Enhertu (Drug) $269,682
- OFEV (Drug) $99,338
- ENHERTU (Drug) $67,416
- Esbriet (Biological) $18,792
- ENHERTU (Biological) $5,187
- Spiration Valve System (Device) $126.66
- IMFINZI (Biological) $125.10
- AMPLATZER AMULET (Device) $18.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Diagnostic Radiology Doctors in San Diego
Dr. Murray Reicher, M.d, M.D
Diagnostic Radiology — Payments: $10.5M
Diagnostic Radiology $10.5M
Dr. Agnes Santosa, M.d, M.D
Diagnostic Radiology — Payments: $2.9M
Diagnostic Radiology $2.9M
Jordan Ziegler, Md, MD
Diagnostic Radiology — Payments: $136,752
Diagnostic Radiology $136,752
Dr. Vishal Verma, Md, MD
Diagnostic Radiology — Payments: $134,466
Diagnostic Radiology $134,466
Gregg Alzate, Md, MD
Diagnostic Radiology — Payments: $81,343
Diagnostic Radiology $81,343
Dr. Giuseppe Ammirati, M.d, M.D
Diagnostic Radiology — Payments: $81,212
Diagnostic Radiology $81,212